Based on the analysis of the patient’s cancer specimen, we found that total PD-1+ T cells in the original cancer were 1.5%, CD3+/PD-1+ T cells were 0.13%, CD8+/PD-1+ T cells were 0.09%. The gene discussed is CD8A; the disease is cancer.